Electrochemical lab on a chip for high-throughput analysis of anticancer drugs efficiency

Rachela Popovtzer, Tova Neufeld, Aron Popovtzer, Ilia Rivkin, Rimona Margalit, Dikla Engel, Abraham Nudelman, Ada Rephaeli, Judith Rishpon, Yosi Shacham-Diamand*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


We describe a new method for rapid, sensitive, and high-throughput detection of colon cancer cells' response to differentiation therapy, using a novel electrochemical lab-on-a-chip system. Differentiation-inducing agents such as butyric acid and its derivatives were introduced to miniature colon cancer samples within the nanovolume chip chambers. The efficacy of each of the differentiation-inducing agents was evaluated by electrochemical detection of the cellular enzymatic activity level, whereas reappearance of normal enzymatic activity denotes effective therapy. The results demonstrate the ability to evaluate simultaneously multiplex drug effects on miniature tumor samples (~15 cells) rapidly (5 minutes) and sensitively, with quantitative correlation between cancer cells' number and the induced current. The use of miniature analytical devices is of special interest in clinically relevant samples, in that it requires less tissue for diagnosis, and enables high-throughput analysis and comparison of various drug effects on one small tumor sample, while maintaining uniform biological and environmental conditions.

Original languageEnglish
Pages (from-to)121-126
Number of pages6
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Issue number2
StatePublished - Jun 2008


  • Bio-MEMS
  • Colon cancer
  • Differentiation therapy
  • Lab-on-a-chip
  • Nanochip


Dive into the research topics of 'Electrochemical lab on a chip for high-throughput analysis of anticancer drugs efficiency'. Together they form a unique fingerprint.

Cite this